Table 1.
Baseline laboratory marker of adult COVID-19 patients at Eka Kotebe General Hospital, COVID-19 Treatment Center, Addis Ababa, Ethiopia, 2021 (n = 602).
| Variables | Mean ± SD | Status | ||
|---|---|---|---|---|
| Death (mean) | Censored (mean) | |||
| Complete cell count | White blood cell (103/µl) | 8.2 ± 5.1 | 13.7 | 7.33 |
| Neutrophil (103/µl) | 6.35 ± 2.6 | 8.78 | 5.94 | |
| Monocyte (103/µl) | 0.50 ± 0.3 | 0.45 | 0.51 | |
| Lymphocyte (103/µl) | 2.6 ± 3.11 | 1.76 | 2.79 | |
| Red blood cell (106/µl | 5.0 ± 4.09 | 4.51 | 5.13 | |
| Hemoglobin (g/dl) | 14.1 ± 2.9 | 13.0 | 14.3 | |
| Hematocrit (%) | 39.77 ± 9.1 | 35.87 | 40.3 | |
| Platelet count (cells/L) | 224.9 ± 95.1 | 184.9 | 231.7 | |
| Renal function test (n = 551) | Urea (mg/dl) | 19.9 ± 8.3 | 22.2 | 19.4 |
| Creatinine (mg/dl) | 1.07 ± 1.00 | 1.72 | 0.95 | |
| Liver function test (N = 551) | Aspartate transaminase (U/L) | 40.20 ± 20.9 | 49.44 | 38.4 |
| Alanine transaminase (U/L) | 42.4 ± 27.45 | 51.6 | 40.69 | |
| Random blood sugar (mg/dl) (n = 419) | 126.18 ± 65.9 | 140.0 | 126.2 | |
| Variable | Category | Death (%) | Censored (%) | Total (%) |
| Blood group (n = 570) | A | 27 (4.75%) | 186 (32.6%) | 213 (37.3) |
| B | 44 (7.72%) | 208 (36.5%) | 252 (44.2%) | |
| AB | 7 (1.23%) | 16 (2.81%) | 23 (4.04%) | |
| O | 9 (1.58%) | 73 (12.81%) | 82 (14.4%) | |